cetylpyridinium chloride anhydrous has been researched along with thiazoles in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennett, BS; Matthews, NS; Mealey, KL; Peck, KE; Sinclair, MD; Taylor, TS | 1 |
| Cortes, J; Han, X; Kantarjian, H; Quintás-Cardama, A | 1 |
| Chen, QX; Huang, WQ; Liu, WZ; Wang, GF; Zhang, JJ | 1 |
2 trial(s) available for cetylpyridinium chloride anhydrous and thiazoles
| Article | Year |
|---|---|
Comparative pharmacokinetics of meloxicam in clinically normal horses and donkeys.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Equidae; Female; Health; Horses; Male; Meloxicam; Species Specificity; Thiazines; Thiazoles | 2006 |
[Pharmacokinetics and relative bioavailability of ziprasidone tablets in Chinese healthy volunteers].
Topics: Administration, Oral; Asian People; Biological Availability; Drug-Related Side Effects and Adverse Reactions; Health; Humans; Piperazines; Tablets; Therapeutic Equivalency; Thiazoles; Time Factors; Young Adult | 2009 |
1 other study(ies) available for cetylpyridinium chloride anhydrous and thiazoles
| Article | Year |
|---|---|
Tyrosine kinase inhibitor-induced platelet dysfunction in patients with chronic myeloid leukemia.
Topics: Benzamides; Blood Coagulation; Blood Platelet Disorders; Dasatinib; Health; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Platelet Aggregation; Protein Kinase Inhibitors; Pyrimidines; Thiazoles | 2009 |